Rhabdoid Tumor - 13 Studies Found

Active, not recruiting : Study of Safety and Efficacy in Patients With Malignant Rhabdoid Tumors (MRT) and Neuroblastoma
: Malignant Rhabdoid Tumors (MRT), Neuroblastoma
: 2012-12-06
: Drug: LEE011 LEE011 is a small molecule inhibitor of CDK4/6.
Active, not recruiting : Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System
: Childhood Atypical Teratoid/Rhabdoid Tumor
: 2008-04-03
:
  • Procedure: autologous hematopoietic stem cell transplantation

Recruiting : Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors
:
  • Malignant Rhabdoid Tumor
  • Atypical Teratoid
  • Drug: alisertib Alisertib will
Terminated : Antineoplaston Therapy in Treating Children With Rhabdoid Tumor of the Central Nervous System
: Rhabdoid Neoplasm of CNS
: 1999-11-01
: Drug: Antineoplaston therapy (Atengenal + Astugenal) Children with a Rhabdoid tumor will receive Antineo
Completed : Studying Biomarkers in Samples From Young Patients With Rhabdoid Tumors
: Kidney Cancer
: 2012-02-29
:
  • Genetic: DNA analysis
  • Genetic: fluorescenc
Completed : Studying Gene Expression in Samples From Patients With Rhabdoid Tumors
:
  • Brain and Central Nervous System Tumors
  • Kidney Cancer

: 2012-03-10
:
  • Genetic: DNA analysis
  • Genetic: gene expres
Withdrawn : Biomarker Study in Samples From Patients With Malignant Rhabdoid Tumor of the Kidney or Atypical Teratoid Rhabdoid Tumor
:
  • Brain and Central Nervous System Tumors
  • Kidney Cancer

: 2011-10-01
:
  • Genetic: RNA analysis
  • Genetic: gene expres
Completed : Oxaliplatin in Treating Children With Recurrent or Refractory Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor
: Brain and Central Nervous System Tumors
: 2002-10-03
: Drug: Oxaliplatin
Completed : Chemotherapy Combined With Radiation Therapy for Newly Diagnosed CNS AT/RT
: Central Nervous System Tumor, Pediatric
: 2004-06-10
:
  • Biological: filgrastim Other N
Recruiting : A Phase 1 Study of the EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma
:
  • Rhabdoid Tumors
  • INI1-negative Tumors